The news is a boon for Moderna, BioNTech and Novavax. While Moderna sells two products, the Covid vaccine Spikevax is easily its biggest moneymaker. BioNTech and Novavax's Covid shots make up the ...
largely tied to weakening demand for its Spikevax COVID-19 vaccine and mRESVIA RSV vaccine. Read Also: Why Novavax Stock Is Volatile This Week The news also intensified concerns about diminishing ...
1 Moderna/Spikevax vaccines, which continue to be free under the programme. Both are mRNA vaccines. In December, MOH said those who wanted to get the Novavax Covid-19 vaccine jab had to do so by ...
1 Pfizer-BioNTech/Comirnaty or JN.1 Moderna/Spikevax vaccines, which continue to be free under the national vaccination programme. The previous Novavax XBB1.5 COVID-19 jab was removed from the ...